Deep Health AI India Ltd
Incorporated in 1993, Deep Diamond India Ltd is in the business of trading Diamond, Jewellery and Pharma products[1]
- Market Cap ₹ 33.6 Cr.
- Current Price ₹ 2.33
- High / Low ₹ 10.3 / 1.65
- Stock P/E 5.39
- Book Value ₹ 1.78
- Dividend Yield 4.29 %
- ROCE 5.28 %
- ROE 4.02 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 98.3% CAGR over last 5 years
Cons
- The company has delivered a poor sales growth of 9.06% over past five years.
- Promoter holding is low: 0.03%
- Company has a low return on equity of 5.06% over last 3 years.
- Earnings include an other income of Rs.4.31 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.55 | 3.13 | 1.17 | 3.29 | 1.66 | 1.25 | 0.81 | 0.51 | 1.39 | 7.67 | 2.56 | 1.25 | 4.45 | |
| 2.69 | 3.04 | 1.40 | 3.38 | 1.94 | 1.54 | 1.11 | 0.74 | 1.38 | 6.03 | 2.80 | 0.80 | 0.92 | |
| Operating Profit | -0.14 | 0.09 | -0.23 | -0.09 | -0.28 | -0.29 | -0.30 | -0.23 | 0.01 | 1.64 | -0.24 | 0.45 | 3.53 |
| OPM % | -5.49% | 2.88% | -19.66% | -2.74% | -16.87% | -23.20% | -37.04% | -45.10% | 0.72% | 21.38% | -9.38% | 36.00% | 79.33% |
| 0.62 | 0.16 | 0.19 | 0.22 | 0.28 | 0.28 | 0.29 | 0.26 | 0.26 | 0.23 | 1.09 | 0.75 | 4.31 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.26 | 0.09 | 0.06 |
| Depreciation | 0.03 | 0.03 | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Profit before tax | 0.45 | 0.22 | -0.09 | 0.09 | -0.02 | -0.03 | -0.03 | 0.01 | 0.27 | 1.73 | 0.58 | 1.10 | 7.78 |
| Tax % | 22.22% | 31.82% | -11.11% | 22.22% | 0.00% | 0.00% | 0.00% | 500.00% | 25.93% | 27.75% | 27.59% | 21.82% | |
| 0.35 | 0.15 | -0.07 | 0.07 | -0.02 | -0.02 | -0.03 | -0.05 | 0.20 | 1.26 | 0.42 | 0.86 | 6.23 | |
| EPS in Rs | 0.04 | 0.02 | -0.01 | 0.01 | -0.00 | -0.00 | -0.00 | -0.01 | 0.02 | 0.13 | 0.04 | 0.09 | 0.45 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 9% |
| 3 Years: | -3% |
| TTM: | 77% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 98% |
| 3 Years: | 68% |
| TTM: | 1732% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 13% |
| 3 Years: | -33% |
| 1 Year: | -46% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 4% |
| 3 Years: | 5% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.99 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 3.20 | 4.81 | 4.81 | 4.81 | 4.81 |
| Reserves | 4.01 | 4.43 | 4.36 | 4.44 | 4.45 | 4.38 | 4.30 | 4.28 | 4.48 | 9.92 | 15.62 | 17.54 | 20.92 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.86 | 1.66 | 0.61 | 0.36 | |
| 0.62 | 0.15 | 0.22 | 0.24 | 0.07 | 0.07 | 0.30 | 0.11 | 0.06 | 1.29 | 0.98 | 0.99 | 2.35 | |
| Total Liabilities | 7.62 | 7.78 | 7.78 | 7.88 | 7.72 | 7.65 | 7.80 | 7.59 | 7.74 | 19.88 | 23.07 | 23.95 | 28.44 |
| 0.45 | 0.40 | 0.36 | 0.32 | 0.30 | 0.29 | 0.27 | 0.00 | 0.00 | 4.47 | 4.46 | 4.45 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.04 | 0.13 | 0.10 | 0.16 | 0.17 | 0.25 | 0.19 | 0.26 | 0.20 | 0.00 | 3.56 | 5.59 | 12.00 |
| 7.13 | 7.25 | 7.32 | 7.40 | 7.25 | 7.11 | 7.34 | 7.33 | 7.54 | 15.41 | 15.05 | 13.91 | 16.43 | |
| Total Assets | 7.62 | 7.78 | 7.78 | 7.88 | 7.72 | 7.65 | 7.80 | 7.59 | 7.74 | 19.88 | 23.07 | 23.95 | 28.44 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.26 | -0.39 | -0.19 | 0.08 | -0.69 | -0.25 | -0.28 | -0.15 | 0.55 | 3.23 | -5.41 | 0.19 | |
| 0.51 | 0.06 | 0.23 | 0.18 | 0.29 | 0.13 | 0.30 | 0.27 | 0.29 | -4.03 | -2.25 | -0.23 | |
| -0.23 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.79 | 5.01 | 0.00 | |
| Net Cash Flow | 0.02 | 0.17 | 0.04 | 0.26 | -0.40 | -0.12 | 0.02 | 0.12 | 0.84 | 4.99 | -2.65 | -0.04 |
| Free Cash Flow | 0.21 | -0.39 | -0.19 | 0.08 | -0.69 | -0.26 | -0.28 | -0.08 | 0.55 | -1.25 | -5.41 | 0.19 |
| CFO/OP | 186% | -433% | 65% | -156% | 246% | 86% | 93% | 65% | 5,700% | 203% | 2,254% | 42% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 154.59 | 213.40 | 455.47 | 142.01 | 167.11 | 169.36 | 202.78 | 293.43 | 118.17 | 127.54 | 208.16 | 148.92 |
| Inventory Days | 889.05 | 446.78 | 1,621.71 | 400.81 | 877.67 | 1,120.30 | 1,942.92 | 3,432.97 | 1,207.61 | 86.55 | 264.73 | 1,241.00 |
| Days Payable | 0.00 | 0.00 | 69.30 | 19.28 | 0.00 | 0.00 | 0.00 | 0.00 | 11.65 | 84.11 | 236.65 | 1,630.33 |
| Cash Conversion Cycle | 1,043.64 | 660.19 | 2,007.88 | 523.53 | 1,044.78 | 1,289.66 | 2,145.70 | 3,726.40 | 1,314.12 | 129.99 | 236.24 | -240.41 |
| Working Capital Days | 918.94 | 798.80 | 2,130.73 | 735.55 | 886.11 | 1,138.80 | 1,662.78 | 2,784.02 | 947.95 | -60.91 | -27.09 | 40.88 |
| ROCE % | 2.31% | 3.01% | -1.18% | 1.18% | -0.26% | -0.39% | -0.40% | -0.40% | 3.30% | 14.24% | 4.03% | 5.28% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory Value INR Hundreds |
|
|||||||||||
| Permanent Employee Count Number |
||||||||||||
| Business Segment Focus - Pharmaceuticals Consultancy Binary (1=Active) |
||||||||||||
| Associate and Subsidiary Entities Count |
||||||||||||
| Manufacturing Facilities (Oasis Ceramics - Acquisition) Count |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of The Company Held On May 04, 2026.
4 May - Board approved rights issue of fully paid equity shares to raise up to ₹25 crore.
-
Board Meeting Intimation for Prior Intimation Pursuant To Regulation 29 Of Securities Exchange And Board Of India (LODR) Regulations, 2015 For The Meeting Of The Board Of The Company Scheduled To Be Held On Monday, May 04, 2026.
28 Apr - Board meeting on May 4, 2026 to consider raising funds via rights issue.
-
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
14 Apr - Registered office shifted from Maharashtra to Rajasthan; ROC moved to Jaipur, CIN updated.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Apr - In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter and Financial Year ended March 31, 2026, based on …
-
Announcement under Regulation 30 (LODR)-Resignation of Director
3 Apr - Independent Director Kailash Chandra resigned effective April 3, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
DDIL is engaged in the business of Rough & Polished Diamonds, sale, and trading of
diamond studded jewellery & Gold
Jewellery, and marketing of pharmaceutical goods and providing consultancy service
to the Pharmaceutical industry